Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|January 9, 2019
Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016)Cecilia G Carvalhaes, Michael D Huband, Harald H Reinhart, et al.
Journal of Global Antimicrobial Resistance|November 21, 2018
Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin AmericaHelio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 13, 2020
Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015-2017)Leonard R Duncan, Helio S Sader, Michael D Huband, et al.
International Journal of Antimicrobial Agents|February 8, 2018
Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)Michael A Pfaller, Michael D Huband, Jennifer M Streit, et al.
Journal of Clinical Microbiology|July 19, 2019
Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor ZoliflodacinAlita A Miller, Maria M Traczewski, Michael D Huband, et al.
Diagnostic Microbiology and Infectious Disease|April 16, 2017
Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study designMichael D Huband, Akinobu Ito, Masakatsu Tsuji, et al.
Open Forum Infectious Diseases|March 22, 2019
Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016Dee Shortridge, Ana C Gales, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance ProgramJoshua M Maher, Michael D Huband, Christopher G Blankers, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 31, 2022
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020)Helio S Sader, Mariana Castanheira, Michael D Huband, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2016
In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014Michael D Huband, Mariana Castanheira, Robert K Flamm, et al.
Pageof 9